Ameritas Investment Partners’s Biodesix BDSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-48
Closed -$2K 3078
2022
Q1
$2K Hold
48
﹤0.01% 3043
2021
Q4
$5K Hold
48
﹤0.01% 3034
2021
Q3
$8K Hold
48
﹤0.01% 2985
2021
Q2
$13K Buy
48
+35
+269% +$11K ﹤0.01% 2880
2021
Q1
$5K Hold
13
﹤0.01% 2996
2020
Q4
$5K Buy
+13
New +$4.05K ﹤0.01% 2964

Other funds holding BDSX

Ameritas Investment Partners's BDSX Position: Q2 2022 in Review

Ameritas Investment Partners sold out of Biodesix (BDSX) in Q2 2022, closing a stake of 48 shares — an estimated $2K sold.

Ameritas Investment Partners first reported a position in BDSX in Q4 2020 and held it in 6 quarters. The position peaked at $13K in Q2 2021. 36 funds tracked by Wall St. Rank hold BDSX as of Q2 2022.

  • Ameritas Investment Partners reported no remaining Biodesix position as of Q2 2022 after selling out during the quarter.
  • Ameritas Investment Partners sold 48 Biodesix shares in Q2 2022, an estimated $2K.
  • Ameritas Investment Partners first reported a position in Biodesix in Q4 2020 and held it in 6 quarters.
  • Ameritas Investment Partners's Biodesix position peaked at $13K in Q2 2021.
  • 36 funds tracked by Wall St. Rank held Biodesix as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.